BioAtla (BCAB) Return on Sales (2020 - 2026)
BioAtla (BCAB) posted quarterly Return on Sales of 0.05% for Q4 2025, up 43.0% year-over-year from 0.03% in Q4 2024, and up 32.44% quarter-over-quarter from 0.07% in Q3 2025.
BioAtla (BCAB) Return on Sales (2020 - 2026) Analysis & Trends
BioAtla's Return on Sales history runs 5 years deep, the most recent figure standing at 0.05% for Q4 2025.
- In Q4 2025, Return on Sales rose 43.0% year-over-year to 0.05%; the TTM figure through Dec 2025 stood at 0.05% (up 42.0% YoY), while the FY2025 annual figure was 0.87%, down 71.0% from the prior year.
- Return on Sales for Q4 2025 stood at 0.05%, up from 0.07% in the prior quarter.
- The five-year high for Return on Sales was 0.01% in Q3 2024, with the low at 8.96% in Q3 2023.
- The 4-year median for Return on Sales is 1.43% (2021), against an average of 2.39%.
- The sharpest annual moves came in 2021 and 2024: Return on Sales tumbled 381 bps in 2021, then soared 894 bps in 2024.
- BioAtla's Return on Sales stood at 4.53% in 2021, then slumped by 98 bps to 8.96% in 2023, then surged by 95 bps to 0.48% in 2024, then soared by 90 bps to 0.05% in 2025.
- Business Quant data shows BCAB's Return on Sales at 0.05% in Q4 2025, 0.07% in Q3 2025, and 0.48% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | BioAtla | 5.28 Mn | 5.28 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Dec 31, 2025 | -0.05% |
| Sep 30, 2025 | -0.07% |
| Dec 31, 2024 | -0.48% |
| Sep 30, 2024 | -0.01% |
| Sep 30, 2023 | -8.96% |
| Dec 31, 2021 | -4.53% |
| Sep 30, 2021 | -4.20% |
| Jun 30, 2021 | -1.82% |
| Mar 31, 2021 | -1.43% |
| Dec 31, 2020 | -0.72% |
| Sep 30, 2020 | -0.54% |
| Jun 30, 2020 | -0.28% |
| Mar 31, 2020 | -0.13% |